The scRNA-seq analysis for the TME of 4T1 tumor bearing mice showed that the mice in the PTX+CKI group had a higher percentage of total T lymphocytes and CD8+ T cells than the PTX-treated mice. This evidence concerns the gene CD8A and neoplasm.